* Phio Pharmaceuticals Corp PHIO.OQ PHIO.O is expected
to show
a rise in quarterly revenue when it reports results on November
8 (estimated).
* The Marlborough Massachusetts-based company is expected
to
report revenue of $12.5 million, according to the estimate from
one analyst, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Phio
Pharmaceuticals Corp
is for earnings of 36 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Phio
Pharmaceuticals Corp is $6, above its last closing price
of $0.57.
This summary was machine generated November 4 at 14:16 GMT. All
figures in US dollars unless otherwise stated